These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 830926)

  • 1. Therapeutic approach to pancreatic extract-induced hyperuricosuria in cystic fibrosis.
    Nouisa-Arvanitakis S; Stapleton FB; Linshaw MA; Kennedy J
    J Pediatr; 1977 Feb; 90(2):302-5. PubMed ID: 830926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis.
    Stapleton FB; Kennedy J; Nousia-Arvanitakis S; Linshaw MA
    N Engl J Med; 1976 Jul; 295(5):246-8. PubMed ID: 934188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricosuria in cystic fibrosis patients treated with pancreatic enzyme supplements. A study of 16 patients in Israel.
    Sack J; Blau H; Goldfarb D; Ben-Zaray S; Katznelson D
    Isr J Med Sci; 1980 Jun; 16(6):417-9. PubMed ID: 6901713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.
    Durie PR; Bell L; Linton W; Corey ML; Forstner GG
    Gut; 1980 Sep; 21(9):778-86. PubMed ID: 7429342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of small vs. large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis: a prospective randomized study.
    Brady MS; Rickard K; Yu PL; Eigen H
    Pediatr Pulmonol; 1991; 10(2):79-85. PubMed ID: 2030925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diseases of the exocrine pancreas in infants and children. A review. 1. Organic pancreatic diseases].
    Niessen KH
    Fortschr Med; 1980 Feb; 98(8):263-8. PubMed ID: 6155320
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancreatic extracts in the management of cystic fibrosis.
    Finberg L
    J Pediatr; 1977 Feb; 90(2):306. PubMed ID: 830927
    [No Abstract]   [Full Text] [Related]  

  • 8. Dietary management of cystic fibrosis.
    Beddoes V; Laing S; Goodchild MC; Dodge JA
    Practitioner; 1981 Apr; 225(1354):557-60. PubMed ID: 7279843
    [No Abstract]   [Full Text] [Related]  

  • 9. Dietary intake of healthy children with cystic fibrosis compared with normal control children.
    Tomezsko JL; Stallings VA; Scanlin TF
    Pediatrics; 1992 Oct; 90(4):547-53. PubMed ID: 1408508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
    Gottschalk B; Wiesemann HG; Stephan U
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis.
    Amarri S; Harding M; Coward WA; Evans TJ; Weaver LT
    Arch Dis Child; 1997 Apr; 76(4):349-51. PubMed ID: 9166030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts: pancreatic extracts.
    Littman A; Hanscom DH
    N Engl J Med; 1969 Jul; 281(4):201-4. PubMed ID: 4892805
    [No Abstract]   [Full Text] [Related]  

  • 13. The management of enzymatic therapy in cystic fibrosis patients by an individualized approach.
    Costantini D; Padoan R; Curcio L; Giunta A
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S36-9. PubMed ID: 3404360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids.
    Kalivianakis M; Minich DM; Bijleveld CM; van Aalderen WM; Stellaard F; Laseur M; Vonk RJ; Verkade HJ
    Am J Clin Nutr; 1999 Jan; 69(1):127-34. PubMed ID: 9925134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the cause of hyperuricosuria in cystic fibrosis patients.
    Niessen KH; Wolf A
    J Pediatr Gastroenterol Nutr; 1982; 1(3):349-54. PubMed ID: 6926538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pancreatic infringement exocrine and endocrine in cystic fibrosis].
    Kessler L; Abély M
    Arch Pediatr; 2016 Dec; 23(12S):12S21-12S32. PubMed ID: 28231890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional supplementation in treatment of cystic fibrosis of the pancreas.
    Allan JD; Mason A; Moss AD
    Am J Dis Child; 1973 Jul; 126(1):22-6. PubMed ID: 4723167
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of cimetidine as an adjunct to supplemental pancreatic enzymes in patients with cystic fibrosis.
    Hubbard VS; Dunn GD; Lester LA
    Am J Clin Nutr; 1980 Nov; 33(11):2281-6. PubMed ID: 7435406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic enzyme replacement therapy in cystic fibrosis: Australian guidelines. Pediatric Gastroenterological Society and the Dietitians Association of Australia.
    Anthony H; Collins CE; Davidson G; Mews C; Robinson P; Shepherd R; Stapleton D
    J Paediatr Child Health; 1999 Apr; 35(2):125-9. PubMed ID: 10365346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caloric intake and eating behavior in infants and toddlers with cystic fibrosis.
    Powers SW; Patton SR; Byars KC; Mitchell MJ; Jelalian E; Mulvihill MM; Hovell MF; Stark LJ
    Pediatrics; 2002 May; 109(5):E75-5. PubMed ID: 11986481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.